Exelixis | EXEL - Capitalizzazione Di Mercato





Capitalizzazione Di Mercato Cambiamento Data
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Akebia Therapeutics USD 427M 297M 2025-12
Amgen USD 209.65B 14.21B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Bayer EUR 48.39B 834.21M 2026-08
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cytokinetics USD 9.6B 1.95B 2026-08
Eisai JPY 1.2T 219.32B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Exelixis USD 15.27B 1.73B 2026-08
Genmab DKK 126.96B 109.86B 2026-08
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MacroGenics USD 184M 82M 2026-03
Merck USD 324.18B 6.81B 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 153.17B 14.73B 2026-08
Sanofi EUR 113.52B 3.82B 2026-03
Takeda JPY 8.2T 809.7B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Xencor USD 1.21B 19M 2026-08